These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20205998)

  • 21. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy.
    Wegner I; Edelbroek P; de Haan GJ; Lindhout D; Sander JW
    Epilepsia; 2010 Dec; 51(12):2500-2. PubMed ID: 21204816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic drug monitoring of gabapentin].
    Tribut O; Bentué-Ferrer D; Verdier MC;
    Therapie; 2010; 65(1):57-60. PubMed ID: 20205997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyponatraemia during oxcarbazepine therapy.
    Pendlebury SC; Moses DK; Eadie MJ
    Hum Toxicol; 1989 Sep; 8(5):337-44. PubMed ID: 2680897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma level monitoring of oxcarbazepine in epileptic patients.
    González-Esquivel DF; Ortega-Gavilán M; Alcántara-López G; Jung-Cook H
    Arch Med Res; 2000; 31(2):202-5. PubMed ID: 10880728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy.
    Rey E; Bulteau C; Motte J; Tran A; Sturm Y; D'Souza J; Markabi S; Pons G; Dulac O
    J Clin Pharmacol; 2004 Nov; 44(11):1290-300. PubMed ID: 15496647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics modeling of oxcarbazepine to characterize drug interactions in Chinese children with epilepsy.
    Wang Y; Zhang HN; Niu CH; Gao P; Chen YJ; Peng J; Liu MC; Xu H
    Acta Pharmacol Sin; 2014 Oct; 35(10):1342-50. PubMed ID: 25220641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxcarbazepine: a review of its use in children with epilepsy.
    Bang L; Goa K
    Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy.
    Striano S; Striano P; Di Nocera P; Italiano D; Fasiello C; Ruosi P; Bilo L; Pisani F
    Epilepsy Res; 2006 May; 69(2):170-6. PubMed ID: 16515857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic children.
    Rodrigues C; Chiron C; Rey E; Dulac O; Comets E; Pons G; Jullien V
    Br J Clin Pharmacol; 2017 Dec; 83(12):2695-2708. PubMed ID: 28771787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of age on lamotrigine and oxcarbazepine kinetics: a historical cohort study.
    Wegner I; Wilhelm AJ; Sander JW; Lindhout D
    Epilepsy Behav; 2013 Oct; 29(1):217-21. PubMed ID: 23995050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy.
    Christensen J; Sabers A; Sidenius P
    Neurology; 2006 Oct; 67(8):1497-9. PubMed ID: 17060586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic drug monitoring of pregabaline].
    Bentué-Ferrer D; Tribut O; Verdier MC;
    Therapie; 2010; 65(1):47-9. PubMed ID: 20205995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxcarbazepine.
    Jensen PK; Gram L; Schmutz M
    Epilepsy Res Suppl; 1991; 3():135-40. PubMed ID: 1777069
    [No Abstract]   [Full Text] [Related]  

  • 34. Amelioration of erectile dysfunction following a switch from carbamazepine to oxcarbazepine: recent clinical experience.
    Sachdeo R; Sathyan RR
    Curr Med Res Opin; 2005 Jul; 21(7):1065-8. PubMed ID: 16004674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic drug monitoring of lamotrigine].
    Bentué-Ferrer D; Tribut O; Verdier MC;
    Therapie; 2010; 65(1):39-46. PubMed ID: 20205994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics and indications of oxcarbazepine].
    Herranz JL; Argumosa A
    Rev Neurol; 2002 Sep; 35 Suppl 1():S101-9. PubMed ID: 12373662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment.
    Friis ML; Kristensen O; Boas J; Dalby M; Deth SH; Gram L; Mikkelsen M; Pedersen B; Sabers A; Worm-Petersen J
    Acta Neurol Scand; 1993 Mar; 87(3):224-7. PubMed ID: 8475694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic drug monitoring of tiagabine].
    Bentué-Ferrer D; Tribut O; Verdier MC;
    Therapie; 2010; 65(1):51-5. PubMed ID: 20205996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical aspects of oxcarbazepine treatment.
    Dam M
    Epilepsia; 1994; 35 Suppl 3():S23-5. PubMed ID: 8156977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oxcarbazepine].
    Arroyo S
    Neurologia; 2001 Oct; 16(8):370-5. PubMed ID: 11738014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.